{"id":"senna","rwe":[{"pmid":"41866261","year":"2026","title":"Adding Senna alkaloid to laxative agents in bowel preparation for pediatric colonoscopy: a clinical trial study.","finding":"","journal":"Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology","studyType":"Clinical Study"},{"pmid":"41806409","year":"2026","title":"Laxative use and acute kidney injury risk: Analysis of a Japanese hospital-based database.","finding":"","journal":"The Journal of pharmacology and experimental therapeutics","studyType":"Clinical Study"},{"pmid":"41802773","year":"2026","title":"Inter-Laboratory Comparison of Photometric and LC Assay Methods for Hydroxyanthracene Glycosides Determination in Senna Herbal Drugs and Dry Extracts.","finding":"","journal":"Planta medica","studyType":"Clinical Study"},{"pmid":"41792543","year":"2026","title":"Towards an attract-and-kill strategy for sustainable tick control: combined effects of Metarhizium anisopliae and phytochemical attractants from Senna didymobotrya against Amblyomma variegatum and Rhipicephalus appendiculatus.","finding":"","journal":"Experimental & applied acarology","studyType":"Clinical Study"},{"pmid":"41791619","year":"2026","title":"The anti-obesity potential of Cassiae Semen: A review based on ethnopharmacology and modern pharmacology.","finding":"","journal":"Journal of ethnopharmacology","studyType":"Clinical Study"}],"_fda":{"id":"083396b6-6a49-ffc7-e063-6294a90ad8e2","set_id":"02a5299c-4b0d-47ac-9838-afd0b0fdd4a6","openfda":{"unii":["F05Q2T2JA0","3FYP5M0IJX"],"route":["ORAL"],"rxcui":["998740"],"spl_id":["083396b6-6a49-ffc7-e063-6294a90ad8e2"],"brand_name":["SENNA-S"],"spl_set_id":["02a5299c-4b0d-47ac-9838-afd0b0fdd4a6"],"package_ndc":["69517-131-25","69517-131-50","69517-131-02","69517-131-24","69517-131-05","69517-131-10"],"product_ndc":["69517-131"],"generic_name":["SENNA AND DOCUSATE SODIUM TABLETS, 8.6 MG AND 50 MG"],"product_type":["HUMAN OTC DRUG"],"substance_name":["DOCUSATE SODIUM","SENNOSIDES"],"manufacturer_name":["HealthLife of USA LLC"],"application_number":["505G(a)(3)"],"is_original_packager":[true]},"purpose":["Active ingredients Purpose (in each tablet) Purpose Docusate sodium 50 mg.......................................Stool softner Sennosides 8.6 mg................................................Laxative"],"version":"9","stop_use":["Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition."],"warnings":["Warnings Do not use if you are now taking mineral oil, unless directed by a doctor laxative products for longer than 1 week unless directed by a doctor Ask a doctor before use if you have stomach pain nausea vomiting noticed a sudden change in bowel habits that lasts over 2 weeks Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition. If pregnant or breast-feeding , ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away."],"questions":["Questions or comments? Call toll free 1-844-832-1138 Monday through Friday 9AM – 5PM EST or www.healthlifeofusa.com"],"ask_doctor":["Ask a doctor before use if you have stomach pain nausea vomiting noticed a sudden change in bowel habits that lasts over 2 weeks"],"effective_time":"20231021","active_ingredient":["Active ingredients Purpose (in each tablet) Purpose Docusate sodium 50 mg.......................................Stool softner Sennosides 8.6 mg................................................Laxative"],"inactive_ingredient":["Inactive ingredients croscarmellose sodium, colloidal silicon dioxide, dicalcium phosphate, D&C Yellow # 10, FD&C Yellow # 6, hypromellose, microcrystalline cellulose, magnesium stearate, maltodextrin, polyethylene glycol, stearic acid, titanium dioxide"],"storage_and_handling":["Other information each tablet contains: calcium 21 mg each tablet contains: sodium 3 mg VERY LOW SODIUM store at 25ºC (77ºF); excursions permitted between 15°-30°C (59°-86°F) read all product information before using TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING"],"indications_and_usage":["Uses relieves occasional constipation (irregularity) generally produces bowel movement in 6-12 hours"],"spl_unclassified_section":["Drug Facts"],"dosage_and_administration":["Directions take preferably at bedtime or as directed by a doctor adults and children 12 years of age or older - starting dosage: 2 tablets once a day, maximum dosage: 4 tablets twice a day children 6 to under 12 years - starting dosage: 1 tablet once a day, maximum dosage: 2 tablets twice a day children 2 to under 6 years - starting dosage: 1/2 tablet once a day, maximum dosage: 1 tablet twice a day children under 2 years - starting dosage: ask a doctor, maximum dosage: ask a doctor"],"spl_product_data_elements":["SENNA-S Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg CROSCARMELLOSE SODIUM SILICON DIOXIDE CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE D&C YELLOW NO. 10 FD&C YELLOW NO. 6 HYPROMELLOSES CELLULOSE, MICROCRYSTALLINE MAGNESIUM STEARATE MALTODEXTRIN POLYETHYLENE GLYCOL 1000 STEARIC ACID TITANIUM DIOXIDE SENNOSIDES SENNOSIDES DOCUSATE SODIUM DOCUSATE S35"],"pregnancy_or_breast_feeding":["If pregnant or breast-feeding , ask a health professional before use."],"keep_out_of_reach_of_children":["Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away."],"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL Compare to the Active Ingredients in Senokot-S® *This product is not manufactured or distributed by Purdue Products L.P., owner of the registered trademark Senokot-S®. Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg Principal Display Panel"]},"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Oral","category":"route"},{"label":"Active","category":"status"},{"label":"constipation","category":"indication"},{"label":"HealthLife of USA LLC","category":"company"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"FATIGUE","source":"FDA FAERS","actionTaken":"3435 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"2865 reports"},{"date":"","signal":"CONSTIPATION","source":"FDA FAERS","actionTaken":"2721 reports"},{"date":"","signal":"DIARRHOEA","source":"FDA FAERS","actionTaken":"2295 reports"},{"date":"","signal":"DYSPNOEA","source":"FDA FAERS","actionTaken":"2285 reports"},{"date":"","signal":"PAIN","source":"FDA FAERS","actionTaken":"2257 reports"},{"date":"","signal":"DEATH","source":"FDA FAERS","actionTaken":"2195 reports"},{"date":"","signal":"PNEUMONIA","source":"FDA FAERS","actionTaken":"2088 reports"},{"date":"","signal":"HEADACHE","source":"FDA FAERS","actionTaken":"2049 reports"},{"date":"","signal":"VOMITING","source":"FDA FAERS","actionTaken":"2017 reports"}]},"trials":[],"aliases":[],"company":"HealthLife of USA LLC","patents":[],"pricing":[{"market":"United States","source":"CMS National Average Drug Acquisition Cost (NADAC)","asOfDate":"2024-01-03","unitCost":"$0.0226/EA","priceType":"NADAC","sourceUrl":"https://data.medicaid.gov/dataset/4j6z-xnwq","annualCost":"$8","description":"SENNA 8.6 MG TABLET","retrievedDate":"2026-04-07"}],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=SENNA","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:10:14.375265+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:10:22.547933+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=SENNA","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:10:23.277927+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:10:12.149165+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:10:12.149204+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T01:10:24.790479+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108558/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:10:23.731889+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"505G(a)(3)","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:10:12.149210+00:00"}},"allNames":"senna-s","offLabel":[],"synonyms":["Senna-S","DOCUSATE SODIUM"],"timeline":[],"approvals":[],"brandName":"Senna-S","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Senna-S contains anthraquinone glycosides, which are metabolized to anthranoid compounds that act as stimulants on the intestinal smooth muscle, increasing peristalsis and promoting the movement of stool through the digestive system."},"commercial":{},"references":[{"id":1,"url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:\"SENNA\"","fields":["mechanism","indications","adverse_reactions","contraindications","warnings","dosage"],"source":"OpenFDA Label"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=senna","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=senna","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:38:05.459804","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:10:27.317482+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://data.medicaid.gov/dataset/4j6z-xnwq","name":"CMS National Average Drug Acquisition Cost (NADAC)","fields":["pricing"],"retrievedDate":"2026-04-07"}],"genericName":"senna","indications":{"approved":[{"name":"constipation","source":"OpenFDA Label","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04930237","phase":"","title":"RELISTOR's Effects on Opioid-Induced Constipation","status":"WITHDRAWN","sponsor":"Methodist Health System","startDate":"2021-07-01","conditions":["OIC"],"enrollment":0,"completionDate":"2022-04-22"},{"nctId":"NCT06335797","phase":"NA","title":"Optimization of Postoperative Bowel Habits","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-10-16","conditions":["Constipation"],"enrollment":88,"completionDate":"2027-05"},{"nctId":"NCT07426133","phase":"NA","title":"Whatsapp Based Patient Education to Improve Bowel Preparation for Colonoscopy","status":"COMPLETED","sponsor":"Shaukat Khanum Memorial Cancer Hospital & Research Centre","startDate":"2025-03-23","conditions":["Assessing Bowel Preparation Quality"],"enrollment":110,"completionDate":"2025-12-26"},{"nctId":"NCT07229066","phase":"NA","title":"The Effect of Video-Based Education on Colonoscopy Preparation","status":"RECRUITING","sponsor":"Eskisehir Osmangazi University","startDate":"2024-06-01","conditions":["Bowel Preparation Quality","Colonoscopy","Patient Education"],"enrollment":246,"completionDate":"2026-03-30"},{"nctId":"NCT07215351","phase":"NA","title":"Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women","status":"RECRUITING","sponsor":"University of Memphis","startDate":"2025-10-07","conditions":["Constipation","Bloating"],"enrollment":30,"completionDate":"2026-01-01"},{"nctId":"NCT00001337","phase":"PHASE2","title":"Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"1993-05-08","conditions":["Diffuse Large B-Cell Lymphoma (DLBCL)","Primary Mediastinal Large B-cell Lymphoma","Burkitt Lymphoma","Anaplastic Large-Cell Lymphoma","Gray Zone Lymphoma"],"enrollment":348,"completionDate":"2024-05-24"},{"nctId":"NCT06825260","phase":"PHASE4","title":"PEG3350 vs Senna After Urogyn Surgery","status":"RECRUITING","sponsor":"St. Joseph's Health, New York","startDate":"2025-04-23","conditions":["Obstructive Defecation Syndrome","Postoperative Constipation"],"enrollment":254,"completionDate":"2027-07"},{"nctId":"NCT03342157","phase":"PHASE2","title":"Docusate/Senna for the Treatment of Diabetic Gastroparesis","status":"TERMINATED","sponsor":"Wake Forest University Health Sciences","startDate":"2018-04-02","conditions":["Diabetic Gastroparesis"],"enrollment":2,"completionDate":"2018-08-17"},{"nctId":"NCT06580366","phase":"PHASE4","title":"Comparing Sennosid A+B and Sodium Picosulfate/Magnesium Oxide/Citric Acid for Bowel Preparation","status":"NOT_YET_RECRUITING","sponsor":"Hitit University","startDate":"2024-08-22","conditions":["Bowel Preparation"],"enrollment":600,"completionDate":"2025-03-22"},{"nctId":"NCT03148002","phase":"PHASE4","title":"Peritoneal Dialysis Pilot Study: Evaluating Polyethylene Glycol (PEG) for Constipation","status":"COMPLETED","sponsor":"Nova Scotia Health Authority","startDate":"2017-07-07","conditions":["Constipation","Peritoneal Dialysis Complication"],"enrollment":25,"completionDate":"2018-06-05"},{"nctId":"NCT06561035","phase":"PHASE3","title":"ACL-R Opioid Sparing Study","status":"ENROLLING_BY_INVITATION","sponsor":"Campbell Clinic","startDate":"2024-09-01","conditions":["Anterior Cruciate Ligament Injuries"],"enrollment":56,"completionDate":"2026-06"},{"nctId":"NCT06021639","phase":"NA","title":"Comparison of Bowel Cleansing Regimens for Colonoscopy","status":"COMPLETED","sponsor":"Mersin University","startDate":"2023-11-20","conditions":["Colonoscopy Preparation"],"enrollment":144,"completionDate":"2024-02-18"},{"nctId":"NCT03491540","phase":"PHASE3","title":"Mechanical Bowel Preparation and Oral Antibiotics Before Rectal Cancer Surgery","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-09-03","conditions":["Rectal Cancer Surgery"],"enrollment":414,"completionDate":"2023-12-12"},{"nctId":"NCT05862519","phase":"NA","title":"A Clinical Study to Evaluate the Efficacy of Four Supplements on Improving Readiness for Intimacy","status":"UNKNOWN","sponsor":"906 CMVI Holdings","startDate":"2023-03-14","conditions":["Libido","Intimacy","Gastrointestinal Issues"],"enrollment":36,"completionDate":"2023-06-13"},{"nctId":"NCT05862532","phase":"EARLY_PHASE1","title":"Gut Microbiome and Blood Markers After Habitual Herbal Tea Consumption","status":"UNKNOWN","sponsor":"Aberystwyth University","startDate":"2022-11-17","conditions":["Obesity","Well-being"],"enrollment":55,"completionDate":"2023-05-31"},{"nctId":"NCT02977286","phase":"PHASE4","title":"Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2017-01-01","conditions":["Constipation"],"enrollment":12,"completionDate":"2019-10-09"},{"nctId":"NCT03501498","phase":"NA","title":"Gut Transit Effect on Enterohepatic Circulation","status":"COMPLETED","sponsor":"University Hospital Plymouth NHS Trust","startDate":"2017-04-10","conditions":["Intestinal Transit"],"enrollment":19,"completionDate":"2022-03-01"},{"nctId":"NCT03475680","phase":"PHASE3","title":"Mechanical Bowel Preparation and Oral Antibiotics Before Colon Cancer Surgery","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-08-08","conditions":["Colon Cancer"],"enrollment":193,"completionDate":"2022-03-23"},{"nctId":"NCT03593252","phase":"NA","title":"Bowel Preparation in Elective Pediatric Colorectal Surgery","status":"UNKNOWN","sponsor":"McMaster University","startDate":"2022-01-01","conditions":["Colostomy","Hirschsprung Disease - Pull Through","Necrotizing Enterocolitis","Inflammatory Bowel Diseases","Meconium Ileus","Bowel Obstruction","Elective Surgery"],"enrollment":81,"completionDate":"2024-01-30"},{"nctId":"NCT01695850","phase":"PHASE2","title":"A Double-blinded,Double-dummy Clinical Trial of Chinese Herbal Medicine (MaZiRenWan) for Functional Constipation","status":"COMPLETED","sponsor":"Hong Kong Baptist University","startDate":"2013-06","conditions":["Functional Constipation","Gastrointestinal Disorders"],"enrollment":291,"completionDate":"2015-08"},{"nctId":"NCT04273295","phase":"NA","title":"Massage With Senna-based Laxatives Versus Senna-based Laxatives in Managing Overflow Retentive Stool Incontinence","status":"COMPLETED","sponsor":"South Valley University","startDate":"2019-04-01","conditions":["Massage"],"enrollment":50,"completionDate":"2019-10-15"},{"nctId":"NCT02720822","phase":"PHASE3","title":"Breathlessness Exertion and Morphine Sulphate","status":"COMPLETED","sponsor":"Flinders University","startDate":"2016-08-08","conditions":["Chronic Obstructive Pulmonary Disease","Dyspnea"],"enrollment":171,"completionDate":"2019-12-20"},{"nctId":"NCT04102566","phase":"PHASE4","title":"Optimizing Pain Control in Transurethral Resection of the Prostate","status":"RECRUITING","sponsor":"Benaroya Research Institute","startDate":"2017-12-08","conditions":["Pain","BPH With Urinary Obstruction","BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms"],"enrollment":50,"completionDate":"2019-12-01"},{"nctId":"NCT01189409","phase":"PHASE4","title":"Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients","status":"TERMINATED","sponsor":"British Columbia Cancer Agency","startDate":"2010-06","conditions":["Constipation","Cancer"],"enrollment":70,"completionDate":"2018-10"},{"nctId":"NCT01575093","phase":"PHASE1,PHASE2","title":"Safety Evaluation of Bowel Cleansing Regimen for PillCam® COLON 2 Capsule Endoscopy","status":"COMPLETED","sponsor":"Medtronic - MITG","startDate":"2012-03","conditions":["Healthy Volunteers"],"enrollment":25,"completionDate":"2012-06"},{"nctId":"NCT02239510","phase":"NA","title":"Efficacy of Linaclotide to Senna for CIC","status":"TERMINATED","sponsor":"TriHealth Inc.","startDate":"2014-09","conditions":["Chronic Idiopathic Constipation"],"enrollment":9,"completionDate":"2016-06"},{"nctId":"NCT03745183","phase":"NA","title":"Senna Alata Leaf Decoction as a Treatment for Tinea Imbricata","status":"COMPLETED","sponsor":"Philippine Dermatological Society","startDate":"2014-11","conditions":["Tinea Imbricata"],"enrollment":20,"completionDate":"2015-01-15"},{"nctId":"NCT02383758","phase":"NA","title":"An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders","status":"COMPLETED","sponsor":"Emory University","startDate":"2015-02-01","conditions":["Encopresis","Autistic Disorder"],"enrollment":22,"completionDate":"2017-01-01"},{"nctId":"NCT02618564","phase":"NA","title":"The Use of Sennosides With Pico Salax in Bowel Preparation for Colonoscopy: a Study of Optimal Dose and Timing","status":"COMPLETED","sponsor":"Queen's University","startDate":"2016-01","conditions":["Colonoscopy Preparation Outcome"],"enrollment":100,"completionDate":"2017-08"},{"nctId":"NCT02481219","phase":"NA","title":"Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure","status":"COMPLETED","sponsor":"Medtronic - MITG","startDate":"2015-05","conditions":["Colorectal Cancer Screening"],"enrollment":122,"completionDate":"2016-02"},{"nctId":"NCT02665624","phase":"PHASE4","title":"Adding Stewed Apricot Juice to Senna Improves the Right-Side and Overall Colon Cleansing Quality for Colonoscopy Preparation","status":"COMPLETED","sponsor":"Camlıca Erdem Hospital","startDate":"2015-04","conditions":["Colonoscopy Preparation"],"enrollment":128,"completionDate":"2015-06"},{"nctId":"NCT00799201","phase":"PHASE4","title":"Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients","status":"TERMINATED","sponsor":"CAMC Health System","startDate":"2007-08","conditions":["Constipation","Analgesia"],"enrollment":3,"completionDate":"2012-10"},{"nctId":"NCT01773096","phase":"PHASE4","title":"Methylnaltrexone Use for Opioid-induced Postoperative Constipation","status":"COMPLETED","sponsor":"Shriners Hospitals for Children","startDate":"2013-05","conditions":["Constipation"],"enrollment":60,"completionDate":"2015-05"},{"nctId":"NCT02008864","phase":"NA","title":"Evaluating the Effect of Senna in Uremic Pruritus","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2011-08","conditions":["End Stage Renal Disease","Pruritus"],"enrollment":60,"completionDate":""},{"nctId":"NCT00990951","phase":"PHASE3","title":"Study of Efficacy of Association of Senna Alexandrina Mill and Associations on Functional Intestinal Constipation","status":"SUSPENDED","sponsor":"Marjan Industria e Comercio ltda","startDate":"2010-06","conditions":["Constipation"],"enrollment":80,"completionDate":"2014-07"},{"nctId":"NCT01140295","phase":"PHASE4","title":"Bowel Preparation for Colonoscopy in Children","status":"TERMINATED","sponsor":"Children's Hospital of Philadelphia","startDate":"2010-09","conditions":["Colonoscopy Preparation"],"enrollment":33,"completionDate":"2011-05"},{"nctId":"NCT00994851","phase":"PHASE3","title":"Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.","status":"COMPLETED","sponsor":"Sanofi","startDate":"2009-09","conditions":["Constipation"],"enrollment":96,"completionDate":"2012-08"},{"nctId":"NCT00662363","phase":"NA","title":"Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation","status":"COMPLETED","sponsor":"Shirley Ryan AbilityLab","startDate":"2008-04","conditions":["Constipation"],"enrollment":64,"completionDate":"2011-10"},{"nctId":"NCT00931853","phase":"PHASE3","title":"Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).","status":"COMPLETED","sponsor":"Sanofi","startDate":"2010-09","conditions":["Constipation"],"enrollment":117,"completionDate":"2011-12"},{"nctId":"NCT01531140","phase":"PHASE4","title":"PEG Versus PEG+Bisacodyl Versus Sennosides for Colon Cleansing Before Colonoscopy","status":"COMPLETED","sponsor":"Medical University of Warsaw","startDate":"2010-11","conditions":["Colonoscopy Preparation"],"enrollment":240,"completionDate":"2011-11"},{"nctId":"NCT00571896","phase":"PHASE2,PHASE3","title":"The Use of SennaS for Prevention of Post-operative Constipation After Urogynecologic Surgery","status":"COMPLETED","sponsor":"Hartford Hospital","startDate":"2008-01","conditions":["Constipation"],"enrollment":72,"completionDate":"2009-06"},{"nctId":"NCT00902031","phase":"NA","title":"Effectiveness of Docusate in Preventing/Treating Constipation in Palliative Care Patients","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2006-04","conditions":["Constipation","Palliative Care"],"enrollment":70,"completionDate":"2010-10"},{"nctId":"NCT00390598","phase":"PHASE2,PHASE3","title":"PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy","status":"COMPLETED","sponsor":"Umeå University","startDate":"2005-09","conditions":["Colonoscopy"],"enrollment":490,"completionDate":"2006-12"},{"nctId":"NCT00460837","phase":"PHASE4","title":"Comparison of Bowel Preparation in Virtual Colonoscopy (VC) - Patient Experience","status":"WITHDRAWN","sponsor":"London North West Healthcare NHS Trust","startDate":"2007-11","conditions":["Colorectal Cancer"],"enrollment":150,"completionDate":"2009-03"},{"nctId":"NCT01057446","phase":"","title":"Comparison of Oral Sodium Phosphate and Sennoside A+B Calcium Lavage for Colonoscopy Preparation","status":"COMPLETED","sponsor":"Maltepe University","startDate":"","conditions":["Colonoscopy"],"enrollment":0,"completionDate":""},{"nctId":"NCT00275184","phase":"PHASE3","title":"Bowel Preparation and Prokinetics in Capsule Endoscopy","status":"UNKNOWN","sponsor":"London North West Healthcare NHS Trust","startDate":"2006-01","conditions":["Small Bowel Disease","Gastrointestinal Hemorrhage","Refractory Anemia"],"enrollment":150,"completionDate":""}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral"},"crossReferences":{"UNII":"F05Q2T2JA0","RXCUI":"998740","SPL_ID":"083396b6-6a49-ffc7-e063-6294a90ad8e2","chemblId":"CHEMBL2108558"},"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"HealthLife of USA LLC","relationship":"Original Developer"}],"publicationCount":1286,"therapeuticAreas":["Metabolic"],"biosimilarFilings":[],"originalDeveloper":"HealthLife of USA LLC","recentPublications":[{"date":"2026 Mar 21","pmid":"41866261","title":"Adding Senna alkaloid to laxative agents in bowel preparation for pediatric colonoscopy: a clinical trial study.","journal":"Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology"},{"date":"2026 Feb 12","pmid":"41806409","title":"Laxative use and acute kidney injury risk: Analysis of a Japanese hospital-based database.","journal":"The Journal of pharmacology and experimental therapeutics"},{"date":"2026 Mar 24","pmid":"41802773","title":"Inter-Laboratory Comparison of Photometric and LC Assay Methods for Hydroxyanthracene Glycosides Determination in Senna Herbal Drugs and Dry Extracts.","journal":"Planta medica"},{"date":"2026 Mar 7","pmid":"41792543","title":"Towards an attract-and-kill strategy for sustainable tick control: combined effects of Metarhizium anisopliae and phytochemical attractants from Senna didymobotrya against Amblyomma variegatum and Rhipicephalus appendiculatus.","journal":"Experimental & applied acarology"},{"date":"2026 Jun 12","pmid":"41791619","title":"The anti-obesity potential of Cassiae Semen: A review based on ethnopharmacology and modern pharmacology.","journal":"Journal of ethnopharmacology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"HealthLife of USA LLC","companyId":"healthlife-of-usa-llc","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:10:27.317482+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}